Auron Therapeutics is developing small molecules therapeutics for solid tumors and hematological malignancies. Auron's approach is to target key drivers of dysregulated differentiation and cellular plasticity in tumors. This type of therapy, called differentiation therapy, reactivates endogenous cellular programs to elicit tumor cell maturation and the transition from cancer to normal tissue. Auron uses an AI-powered platform, AURigin, to identify new drug targets.

<p>Auron Therapeutics is developing small molecules therapeutics for solid tumors and hematological malignancies. Auron&#39;s approach is to target key drivers of dysregulated differentiation and cellular plasticity in tumors. This type of therapy, called differentiation therapy, reactivates endogenous cellular programs to elicit tumor cell maturation and the transition from cancer to normal tissue. Auron uses an AI-powered platform, AURigin, to identify new drug targets.</p>


Auron Therapeutics

Founded: 2018
Location: Newton, MA
Employee range: 1-50
Clinical stage: RD/Clin0
Therapy area: Prostate cancer
Drug types: ONC
Lead product: AUTX-703
Funding: 10-100M

Drug notes:

About:

Jobs: